Gabriella De Vita

Prof. Gabriella De Vita

Università degli Studi di Napoli Federico II
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in Cell
Verified
Journal Article
Closed access
PLPablo Landgraf
Pablo Landgraf
MRMirabela Rusu
Mirabela Rusu
RSRobert Sheridan
Robert Sheridan
ASAlain Sewer
Alain Sewer
NINicola Iovino
Nicola Iovino
TTThomas Tuschl
Thomas Tuschl

1 March 2006 in Cell
Verified
Journal Article
Closed access
PVP. Mathijs Voorhoeve
P. Mathijs Voorhoeve
CSCarlos le Sage
Carlos le Sage
MSMariette Schrier
Mariette Schrier
AGAd J.M. Gillis
Ad J.M. Gillis
HSHans Stoop
Hans Stoop
RAReuven Agami
Reuven Agami

1 February 2007 in Cancer Cell
Verified
Journal Article
Closed access
IDIgnacio Dolado
Ignacio Dolado
ASAneta Swat
Aneta Swat
NANuria Ajenjo
Nuria Ajenjo
GVGabriella De Vita
Gabriella De Vita
ACAna Cuadrado
Ana Cuadrado
ANAngel R. Nebreda
Angel R. Nebreda

13 October 2008 in Oncogene
Verified
Journal Article
Closed access
FTF Talotta
F Talotta
Amelia CimminoAmelia Cimmino
Amelia Cimmino
MMM R Matarazzo
M R Matarazzo
Laura CasalinoLaura Casalino
Laura Casalino
GVGabriella De Vita
Gabriella De Vita
PVP Verde
P Verde

15 July 1991 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MMM C Magli
M C Magli
PBP Barba
P Barba
ACA Celetti
A Celetti
GVGabriella De Vita
Gabriella De Vita
CCC Cillo
C Cillo
EBE Boncinelli
E Boncinelli
Hematopoiesis is a continuous process in which precursor cells proliferate and differentiate throughout life. However, the molecular mechanisms that govern this process are not clearly defined. Homeobox-containing genes, encoding DNA-binding homeodomains, are a network of genes highly conserved throughout evolution. They are organized in clusters expressed in the developing embryo with a positional hierarchy. We have analyzed expression of the four human HOX loci in erythroleukemic, promyelocytic, and monocytic cell lines to investigate whether the physical organization of human HOX genes reflects a regulatory hierarchy involved in the differentiation process of hematopoietic cells. Our results demonstrate that cells representing various stages of hematopoietic differentiation display differential patterns of HOX gene expression and that HOX genes are coordinately switched on or off in blocks that may include entire loci. The entire HOX4 locus is silent in all lines analyzed and almost all the HOX2 genes are active in erythroleukemic cells and turned off in myeloid-restricted cells. Our observations provide information about the regulation of HOX genes and suggest that the coordinate regulation of these genes may play an important role in lineage determination during early steps of hematopoiesis.

18 October 2010 in Oncogene
Verified
Journal Article
Open access
PDF file
DFDaniela Frezzetti
Daniela Frezzetti
MMM De Menna
M De Menna
PZPietro Zoppoli
Pietro Zoppoli
CGCarmen Guerra
Carmen Guerra
Angelo FerraroAngelo Ferraro
Angelo Ferraro
GVGabriella De Vita
Gabriella De Vita
MiR-21 is a microRNA (miRNA) frequently overexpressed in human cancers. Here we show that miR-21 is upregulated both in vitro and in vivo by oncogenic Ras, thus linking this miRNA to one of the most frequently activated oncogenes in human cancers. Ras regulation of miR-21 occurs with a delayed kinetic and requires at least two Ras downstream pathways. A screen of human thyroid cancers and non-small-cell lung cancers for the expression of miR-21 reveals that it is overexpressed mainly in anaplastic thyroid carcinomas, the most aggressive form of thyroid cancer, whereas in lung its overexpression appears to be inversely correlated with tumor progression. We also show that a LNA directed against miR-21 slows down tumor growth in mice. Consistently, a search for mRNAs downregulated by miR-21 shows an enrichment for mRNAs encoding cell cycle checkpoints regulators, suggesting an important role for miR-21 in oncogenic Ras-induced cell proliferation.